Clara cell-specific 1o-m protein (CCSP) is an abundant product of nonciliated bronchiolar epithelial (Clara) cells in the lung. We have determined the temporal-spatial distribution of CCSP and its mRNA in developing human lung and in neonatal lung disease, using immunohistochemistry and in situ hybridization. CCSP immunoreactivity was found in noncitiated bronchiolar epithelial cells from 12 weeks of gestation onward. Tracheal and bronchial epithelia showed positive immunoreactivity at each gestational week after 15 weeks and 14 weeks, respaaively. CCSP mRNA was seen in the bronchial and bronchiolar epithelia from 16 weeks onward and was detected in the trachea from 19 through 23 weeks ofgestation. CCSPimmunodvity andmRNAwere present in nonciliated single ails of bronchial and bronchiocells (Nettesheim et al., 1990). In the developing lung of the rabbit fetus, almost all of the proliferating bronchiolar epithelial cells are nonciliated at 28 days of gestation, a portion ofwhich becomes ciliated by 30 days of gestation (Plopper et al., 1992). Clara cell-specific 10 KD protein (CCSP), an abundant secretory product of Clara cells, constitutes approximately 4.4% ofsoluble * A-0109 Medical Center North, Nashville, TN 37232-2370. lar epithelia in fetuses and in infants with and without lung disease. CCSF and CCSP mRNAantaining epithelial cells also formed dusters around neuroepithelial bodies (NEBs), especially at airway branch poinu, suggesting that NEBs and Clara Celts might interact during development and during pulmonary regeneration. Because of evidence of overlapping of some but not all cells expressing CCSP, SP-A, and pro-SP-B during lung development, a common cell lineage is proposed, with subsequent divergence of phenotypes. ( J ~'stochem CJrtochem 44: 1&9-1438, 19%) 
Introduction
The Clara cell, a nonciliated epithelial cell of the distal conducting airways (Clara, 1937) , is believed to be a progenitor for itself and for ciliated cells of the bronchioles. The role of Clara cells as progenitors of conducting airway epithelial cells of the lung has been established primarily by experimental studies. Electron microscopic autoradiography of rat lungs exposed to NO2 or 0 3 demonstrated that these nonciliated bronchiolar epithelial cells divide and are precursors of new nonciliated and ciliated cells (Evans et al., 1976) . This pleuripotential characteristic of Clara cells was confirmed by autoradiographic studies of other lung injury models (Ogawa et al., 1993) and by cell culture studies of rabbit conducting airway proteins in rabbit lung lavage (Gupta et al., 1987) and is believed to be a marker for Clara cells in several different species (Singh et al., 1988a) . The recently identified thyroid transcription factor-1 ( m i ) , a homeodomain-containing nuclear transcription protein, activates the expression of CCSP gene transcription as well as that of surfactant proteins (SPs) A , B, and C in a respiratory epitheliumspecific manner (Bohinski et al., 1994) . Cells expressing SP-A and SP-B have been found in conducting airways of human fetuses and newborns in nonciliated cells phenotypically similar to Clara cells (Mantile et al., 1993; Singh et al., 1990) .
There is evidence that human Clara cell 1o-m protein is the counterpart of rabbit uteroglobin (Mantile et al., 1993; . Like uteroglobin, CCSP is an excellent substrate for transglutaminase and is a potent inhibitor of human synovial phospholipase A 2 , suggesting that it plays a role in regulating inflammatory responses.
The relationship between Clara cells and other epithelial cells of potentially distinct lineage, including neuroepithelial bodies (NEBs) and cells expressing surfactant-associated proteins is of interest. Neuroepithelial bodies are clusters of neuroendocrine cells that appear in human lung as early in fetal life as 8 weeks' gestation in conducting airways, especially at branch points (Stahlman and Gray, 1984) . They are believed to have both neural and endo-crine functions and to express a variety of hormones, growth factors and neurotransmitters. In the human fetus, nerve endings, both afferent and efferent, have been described embedded in the NEB (Stahlman and Gray, 1984) . Some NEBs are believed to act as chemoreceptors participating in local ventilation-perfusion ratio regulation (Youngson et al., 1993 ; Lauweryns and Van Lommel, 1986 ; Lauweryns et al., 1978 Lauweryns et al., , 1983 ; Laumryns and Peuskens, 1972) .
They are numerous in the lungs of second trimester human fetuses. As term approaches, the number of NEBS decreases. With the development of chronic lung disease postnatally, i.e., bronchopulmonary dysplasia (BPD), they are again found in increased numbers ; Johnson et al., 1982) .
The purpose ofthis study was (a) to determine the temporal-spatial distribution of CCSP and its mRNA in the developing human lung and in neonatal lung disease and (b) to examine the relationship between airway epithelial cells expressing CCSP and other epithelial cells of potentially different lineage, including neuroendocrine cells (NEs), neuroepithelial bodies (NEBS), and cells expressing surfactant-associated proteins.
Materials and Methods
Tissue Preparation. This was a retrospective study that was approved by the Committee for the Protection of Human Subjects, Vanderbilt University Medical Center. Tissues were obtained with parental consent at hysterotomy or hysterectomy abortion, at surgical or postmortem biopsy, or at autopsy. Many tracheal specimens were not obtained. Some autopsies were limited to lung only, and three specimens were obtained at lobectomy. Because the source of very immature fetal tissues is no longer available, the number of cases is limited at early gestational ages. Lung tissue was immunostained for CCSP in 41 fetuses (10-23 weeks of gestation), 13 liveborn infants without significant pulmonary pathology (25-42 weeks of gestation, 15 min to 30 days postnatal age), 23 infants with acute hyaline membrane disease (HMD) (22-32 weeks of gestation, 1.5 hr to 2 days postnatal age), 15 infants with regenerating HMD (60 hr to 10 days postnatal age), 15 infants with early BPD (12-35 postnatal days), and nine infants with late BPD (35 days to 7 months of postnatal age). Tracheas were available from 15 fetuses. Tracheas from liveborn infants were not examined because of extensive epithelial damage in most tracheal specimens. Not all tissue specimens were considered satisfactory for in situ hybridization. Many of the paraffin blocks had been stored for many years and were excluded from in situ hybridization studies because of potential damage to tissue RNA. In situ hybridization for CCSP mRNA was analyzed in lung tissue from 25 fetuses, four infants without pulmonary pathology, nine infants with HMD, four infants with regenerating HMD, nine infants with early BPD, and four infants with late BPD. Tracheas from 12 fetuses were analyzed by in situ hybridization. Tissues were fixed in 10% phosphatebuffered formalin, in most cases within 2 hr after death, dehydrated through graded ethanols, and embedded in paraffin. Four-pm-thick serial sections were cut and mounted separately on Superfrost Plus (Fisher; Atlanta, GA) glass slides.
Antibodies. The preparation and purification of the rabbit antiserum to human CCSP have been described earlier (Singh et al., 1988a) . In serial sections of selected cases, NEBS were identified with rabbit antisera to bombesin (Incstar; Stillwater, MN), calcitonin gene-related peptide (CGRP) (Peninsula; Belmont, CA), calcitonin (Dako; Carpinteria, CA), and serotonin (Incstar). In other serial sections, the cellular distribution of CCSP immunoreactivity was compared to that of SP-B precursor (pro-SP-B) and SP-A. The rabbit pro-SP-B antiserum (a kind gift of Dr. Jeffrey A. Whitsett) was generated against recombinant human pro-SP-B expressed in E. coli (OReilly et al., 1989) . Antibodies to SP-A, purified from alveolar lavage and subjected to endoglycosidase digestion and p-elimination. were prepared in rabbits and absorbed with red cells from each ofthe four major blood groups as previously described (Khoor et al., 1993) . Rabbit anti-'ITFl serum was kindly provided by Dr. Roberto DiLauro (Station Zoology Anton Dohra, Villa Communale, Naples, Italy).
Immunohistochemistry. Localization of immunoreactive CCSP was carried out with the peroxidase-anti-peroxidase (PAP) method of Sternberger (1979). Sections were deparaffinized, hydrated, treated with 0.3% hydrogen peroxide in methanol, and exposed to 10% normal swine serum to eliminate nonspecific staining. The sections were incubated with the primary antibody at room temperature overnight. After washing, sections were exposed to a swine antiserum to rabbit immunoglobulin, washed again, and treated with horseradish peroxidase coupled to rabbit anti-peroxidase. The peroxidase activity was then localized by reaction with a solution containing 0.05% 3.3'-diaminobenzidine and 0.01% hydrogen peroxide and sections were counterstained with hematoxylin. Normal rabbit serum controls for each antibody used were run on all sections.
Probe Preparation. The 367-BP human CCSP cDNA (Singh et al., 1988b) was inserted into a pBluescript I1 SK+ transcription vector (Stratagene; LaJolla, CA). Labeled RNA transcripts of this cDNA identify a 0.6 KB CCSP band in Northern blot analysis of human lung RNA (Singh et al., 1988b) . The orientation of the subcloned cDNA with respect to the T3 and T7 promoters was determined by restriction map analysis. Sense and antisense RNA probes were synthesized by in vitro transcription. The reaction mixture contained a linearized DNA template, 5'[a-35S]-UTP (NEN, Boston, MA; 1000-1500 CilmM), reagents of a transcription kit (Riboprobe Gemini I1 Core System; Promega, Madison, WI), and T3 (Stratagene) or T7 (Promega) RNA polymerase. Radiolabeled probes were reduced to an average length of 100 bases by limited alkaline hydrolysis (Cox et al., 1984) and were separated from unincorporated nucleotides by Sephadex G-50 column chromatography. Before hybridization, probes were sized on denaturing agarose gels to determine that the limited alkaline hydrolysis reduced the probe to the optimal length ( 1 0 bases).
In Situ Hybridization. In situ hybridization was performed as described previously (Pelton et al., 1991) with modifications (Khoor et al., 1994) .
Briefly, tissue sections were deparaffhized in xylene (twice for 10 min), rehydrated through a graded ethanol series (100% to 30%). rinsed in 1 x PBS (5 min), and postfiied in a freshly prepared solution of 4% puaformaldehyde in 1 x PBS (20 min). Slide were then rinsed in 1 x PBS (twice for 5 min) and treated with a fresh solution of proteinase K (1 Wglml) in 50 mM Tris-HC1, pH 8.0,5 mM EDTA (30 min at 37'C). Slides were then rinsed in 1 x PBS (5 min), refixed in the same paraformaldehyde solution ( 5 min), quickly dipped in distilled water, and acetylated in freshly prepared 0.25 % acetic anhydride in 0.1 M triethanolamine (twice for 10 min).
Slides were subsequently rinsed in 1 x PBS (5 min), dehydrated through the ethanol series (30% to 100%). and dried in a slide drier (Oncor; Gaithersburg, MD). Tissue sections were covered with a hybridization solution that contained 2 x lo4 cpmlpl sense or antisense probe, 50% formamide, 0.3 M NaCI, 10 mM Tris, pH 8.0, 10 mM NaP04, 0.5 mM EDTA, 1 x Denhardt's solution, 10% dextran sulfate, 0.2 mglml yeast RNA, and 10 mM dithiothreitol. Tissue and probe were covered with a siliconized coverslip and hybridized in a humid chamber (overnight at 55'C). After hybridization, coverslips were removed in 5 x SSC (1 x SSC = 150 mM NaCI, 15 mM sodium citrate), 20 mM P-mercaptoethanol (BME) (1 hr at 5O'C). Slides were washed in 50% formamide, 2 x SSC, 200 mM BME (20 min at 65"C), rinsed in 1 x TEN (10 mM Tris, pH 7.5, 0.5 mM EDTA, 0.5 M NaCI) (twice for 10 min at 37'C), treated with a solution of RNAse A (20 pglml) and RNAse T1 (1 Ulml) in 1 x TEN (30 min at 37'C). and rinsed again in 1 x TEN (twice for 10 min at 37'C). Slides were then washed in 50% formamide, 2 x SSC, 200 mM BME (20 min at 65'C).
in 2 x SSC (twice for 15 min at 65%). and in 0 . 1 x SSC (twice for 15 min at 65 'C). Slides were dehydrated through graded ethanols containing 0 . 3 M ammonium acetate, dried, dipped in 50% Ilford K.5 emulsion in 1 % glycerol, and dried again. After 6 days of exposure, autoradiographs were developed in Kodak D-19 and counterstained with 0.04% toluidine blue. The specificity of hybridization was established by sense probes that did not hybridize above the background levels observed with the antisense probes.
Factors such as antibody titer and length of autoradiography were determined in preliminary studies and were not changed in subsequent procedures. In the preliminary studies, more than 6 days of exposure resulted in unacceptably high background, and therefore 6-day exposure was used in later studies.
Results

DistTibution of CCSP in Fetal Lung from 10
Through 23 Weeks of Gestation Table 1 shows the temporal-spatial distribution of CCSP and CCSP mRNA in the respiratory tract of fetuses at 10 through 23 weeks of gestation. Immunolabeling for CCSP was present in the earliest trachea available (12 weeks of gestation) and some immunolabeled cells were present in most available tracheas thereafter, being consistently present at each gestational week after 15 weeks. Rare epithelial cells of tracheal and bronchial glands were immunolabeled. In bronchi of very young fetuses, a few clusters of immunolabeled cells surrounding NEBs were detected. By 16 weeks of gestation, scattered single immunolabeled epithelial cells were observed in bronchi. In one of the two youngest available fetuses (10 weeks), immunolabeled cells were seen in bronchioles in close association with NEBs. From 12 weeks onward these cells appeared in most fetuses as a crown over the luminal surface of the NEB, extending along the lateral surfaces of the NEB down to the basement mem- Figures 1 and 2) . This shell-like configuration of Clara cells around neuroepithelial cells of the NEB was characteristic of their appearance in bronchioles throughout fetal life ( Figure 3 ). By 18 weeks of gestation, scattered immunolabeled single cells were identified in bronchioles in addition to those cells associated with NEBs ( Figures 4 and 5) . Thereafter, increasing numbers of Clara cells appeared both singly or in small clusters in association with NEBs in both bronchi and bronchioles.
CCSP mRNA, as detected by in situ hybridization, was seen in the bronchial and bronchiolar epithelia from 16 weeks onward (Figure 6) and was present in available tracheas from 19 to 23 weeks. The cellular distribution of CCSP and its mRNA in the bronchiolar epithelium was different from that in the tracheobronchial epithelium. In tracheobronchial epithelium, CCSP immunoreactivity and CCSP mRNA were detected predominantly in scattered single cells. In the bronchiolar epithelium, however, most of the CCSP and its mRNA-containing cells formed clusters around NEBs, especially at airway branch points ( Figure 7 ).
Infints of 25-42 Weeks of Gestation
In newborn infants who died of nonpulmonary causes, CCSP immunoreactivity and mRNA were localized predominantly to single cells in bronchi ( Table 2) . A few immunoreactive cells were also seen in bronchial glands. Similar to their distribution in fetuses, CCSP-and CCSP "A-containing cells of the bronchiolar epithelium frequently formed clusters around NEBs (Figures 8 and 9 ).
Infants with Acute and Regenerating HMD (25-34 Weeks of Gestation)
Infants that died of HMD within 2 days demonstrated characteristic pathological features including hyaline membranes, scattered foci of alveolar hemorrhage, and edema. In those lung sections containing bronchi, single CCSP-immunoreactive cells were seen. These immunoreactive cells were located predominantly in epithelial folds. Before 40 postnatal hr, only rare CCSP-immunolabeled cells were seen in denuded bronchioles ('Igble 3). Thereafter, as relining occurred, many positive single cells and clusters around NEBs were seen. CCSP mRNA was also present in the bronchial and bronchiolar epithelia in a cellular distribution pattern similar to that of CCSP immunoreactivity.
Infants wzth BPD
The pathology of infants in this category encompassed the entire spectrum of BPD (Xble 3). Fifteen infants who survived for 15 to 35 postnatal days were considered early BPD, and nine infants who survived for 35 postnatal days through 7 postnatal months were considered late BPD. Tracheas were not examined because of denudation and/or squamous metaplasia. Of these early BPD infants with bronchi in the sections, positive single cells were present in the absence of squamous metaplasia and rare immunolabeled cells were present in bronchial glands. The bronchioles of these infants exhibited immunostaining of some single cells, especially in deep folds, and a few NEBs were associated with CCSP-positive cell clusters, increasing with postnatal age (Figure 10 ). Tissue was considered appropriate for in situ hybridization in nine of these infants. Two thirds of the sections with bronchi showed CCSP mRNA and bronchial glands of one were labeled. However, bronchioles showed mRNA for CCSP in all but two infants, one ofwhose bronchioles were lined with dysplastic cells, or with those undergoing squamous metaplasia.
After 35 postnatal days, available bronchi had immunolabeled single cells. However, there were many NEBs in bronchioles of these infants, which were associated with CCSP-positive clusters of cells or crowns on the luminal surface of the NEB. Single cells immunolabeled for CCSP were also present in a few instances, as well as in cells that were clearly dysplastic. Available bronchi and bronchioles of four infants with late BPD were positive for CCSP mRNA, and three had positive cells in bronchial glands. 
CCSPla&eled Cells in Relation to Other Cell Types
In 16 selected cases, five serial lung sections were immunostained for CCSP, bombesin, calcitonin, CGRP, and serotonin. The CCSP antibody was always applied to the third or center section. Eight of these cases were fetuses of 12 to 23 weeks' gestation, four were livebom infants that died without pulmonary disease, and four died with pulmonary disease between 45 hr and 7 postnatal months. In NEBs surrounded by CCSP-immunolabeled cells, one or more and occasionally all four of these markers for NE cells were identified (Figures 11-14) . Calcitonin, as reported previously, was present only in NEBs after 21 weeks of gestation (Stahlman et d., 1985) .
In no instance was CCSP observed to overlap with cells labeling with the neuroendocrine peptides or with serotonin. In nine other selected cases, serial sections were immunostained with CCSP and pro-SP-B antibodies. Because of the thickness of light microscopic sections, co-localization was sometimes difficult to establish with certainty. In some instances there appeared to be co-localization of CCSP and pro-SP-B in the same cell. However, in many instances these two antibodies appeared to label two differ-ent cell populations in the conducting airways. Cells with CCSP immunoreactivity were located predominantly in epithelial folds. Pro-SP-B-immunoreactive cells were more widespread in their cellular distribution (Figures 15 and 16 ). In no instance was pro-SP-B labeling associated with NEBs.
Five serial sections were also immunostained with both CCSP and SP-A. In most instances there was no convincing evidence of overlapping immunolabeling in the lung. In no instance was SP-A associated with NEBS. However, in the fetal trachea, cells flanking deep folds, interpreted to be origins of gland necks, were immunolabeled both for CCSP and for SP-A, the latter also being present in some adjacent submucosal glands.
Serial sections of lung tissue from two subjects that were known to contain many NEBS, one a normal 23-week fetus, the second an infant with BPD, were immunostained for CGRP, TITI, and serotonin. Many of the same NEBs were identified in all three sections. TITI uniformly immunolabeled nuclei of Clara cells overlying NEBs, but in no instance was TIT1 nuclear labeling observed in NEB cells immunolabeled with CGRP or serotonin. zgure 9. Bronchiole from the lung of an infant of 40 weeks' gestation who survived for 10 dayslwhich was hybridized in situ to an antisense CCSP probe and photographed with darkfield illumination. CCSP mRNA is expressed in many epithelial lining cells. Original magnification x 960, Bar = 10 pm. 
Nonpulmonary Tissue Immunostained for CCSP
Selected nonpulmonary tissue sections from 13 subjects of various ages were also immunostained with CCSP antibody. These included stomach, large intestine, duodenum, pancreas, uterus, including endocervical glands, testis, prostate, and epididymis. All were negative, with the exception of sections of the transitional epithelium of the prostatic urethra in three subjects, where scattered positively labeled cells were seen. some at the surface and some in folds.
Discussion
In this study, CCSP protein and mRNA were localized in nonciliated cells of the tracheal, bronchial, and bronchiolar epithelia in fetuses, including tracheobronchial glands. In newbom infants a similar spatial distribution was seen in the lung, but tracheas were not examined. Nonciliated columnar cells of the lining epithelia of bronchi and bronchioles immunolabeled by CCSP have been demonstrated previously in the human lung (Singh et al., 1988a) . Our findings are also in agreement with in situ hybridization studies demonstrating that the CCSP gene is expmsed in both bronchial and bronchiolar epithelia in adult humans (Btoers et al., 1992) . Immunohistochemical studies in rabbits have indicated that cells of both trachea and bronchioles synthesize and secrete CCSP (Patton et al., 1991) . In RNA blot analysis of developing rat lung, CCSP gene expression is not confined to the lung but is also seen in the trachea (Hackett et al., 1992) . In Syrian golden hamsters, CCSP immunoreactivity and mRNA have been observed in secretory cells of the trachea, bronchi, and bronchioles (Strum et al., 1990 (Strum et al., , 1992 . liken together, these data indicate that the CCSP gene is expressed not only in bronchiolar Clara cells but also in nonciliated cells of the trachea and bronchi in several mammalian species, including those of humans, at various stages of development.
CCSP immunoreactivity was identified in one 10-week fetus in "crowns" over NEBs and was present in bronchioles in this configuration at all gestational weeks from 12 weeks onward. In these fetuses, the same configuration was found in bronchi at each gestational week after 14 weeks. CCSP immunoreactivity appeared in single cells in tracheal epithelium at each gestational week after 15 weeks. CCSP mRNA was seen in the bronchial and bronchiolar epithelia from 16 weeks onward and was present in a d a b l e tracheas after 19 weeks' gestation. Many of the paraffin blocks had been stored for many years and were excluded from in situ hybridization studies because of potential tissue RNA damage. The earlier appearance of CCSP than of CCSP mRNA is most likely due to differences in the ability of the two techniques to detect the same strength of signal, depending on such factors as antibody titer and length of autoradiography. In another study, CCSP immunoreactivity appeared at 21 weeks' gestation in the human lung (Singh et al., 1988a) . These data suggest that Clara cell cytodifferentiation occurs early during human lung development. Compared with human lung, CCSP expression and mRNA appear relatively late in fetal life in the lungs of several mammals studied, with most of the expression appearing postnatally (Cardoso et al., 1993; Ten Have-Opbroek and De Vries, 1993; Hackett et al., 1992; Strum et al., 1990) . Differentiation of bronchial epithelium and CCSP expression in the mouse have been shown to be coincident with the loss of SP-C expression in bronchi, which is now expressed in distal respiratory epithelium (Wert et al., 1993) . The early appearance of cells expressing CCSP in developing human lung raises quations regarding their possible intrauterine role as progenitor cells.
TTFi is a transcription factor for CCSP and for all surfactantassociated proteins. During early lung development, some cells expressing CCSP also may express pro-SP-B and SP-A, although not all CCSP-expressing cells have this capability throughout gestation. The appearance of CCSP, SP-B, and SP-A in respiratory epithelial cells early in human gestation raises the possibility that nonciliated cells in conducting airways may be of a common lineage that later diverges into populations with different roles. Whereas CCSP expression is spatially closely associated with NEBs, neither SP-B-nor SP-A-expressing cells appear to have this association.
This report describes a close spatial relationship between Clara cells and NEBs. In fetuses, nonciliated bronchiolar epithelial cells immunolabeled for CCSP or containing CCSP mRNA formed clusters around NEBs, especially at airway branch points. Several studies suggest a role for peptides secreted by pulmonary neuroendocrine cells (PNECs) and NEBs in regulating airway epithelial growth. The expression of bombesin-like peptides by PNECs is transiently upregulated during mouse lung development (Sunday et al., 1990) . Mammalian bombesin (gastrin-releasing peptide) stimulates growth of human bronchial epithelial cells in colony-forming assays (Siegfried et al., 1993) . In an in vitro model using lung buds, treatments with bombesin resulted in increasing branching morphogenesis (King et al., 1995) . CGRP causes proliferation of guinea pig tracheal epithelial cells in primary culture through stimulation of a specific receptor (White et al., 1993) . We have identified these peptides in NEBs surrounded by clusters of CCSPimmunolabeled cells. In lungs of newborn Syrian golden hamsters exposed continuously to tritiated thymidine throughout the final 4.5 days of gestation, the accumulated autoradiographic label was greater in airway epithelial cells nearer a NEB than in those farther away (Hoyt et al., 1991 (Hoyt et al., ,1993 . It has been shown that, after acute Clara cell injury, regeneration was most prominent in injured airways at branch points. Because NEBs covered with Clara cells in both developing lung and in lung recovering from injury, such as BPD, appear prominently at branch points, these sites may be important in providing regenerating cell populations (Stripp et al., 1995) . 'Men together, these studies suggest that the neuroendocrine cells of NEBs and Clara cells may interact, significantly affecting proliferation or differentiation during lung development and after injury.
This study also analyzes the relationship of Clara cells and NEBs in the course of neonatal lung disease. The number of cells containing CCSP and CCSP mRNA was variable in lungs with acute HMD and regenerating HMD, presumably owing to epithelial injury. As lung injury became chronic, associated with the extensive pathology of BPD, CCSP protein expressing cells were again commonly seen and often formed "cmns" around NEBs. CCSP mRNA was present in bronchioles after 28 postnatal days. Previous studies of the same material have shown that PNEC and NEBs are numerous in infants with advanced BPD (Johnson et al., 1988; Stahlman et al., 1985 Stahlman et al., ,1987 Stahlman and Gray, 1984) . PNEC hyperplasia has been demonstrated in BPD in other studies as well (Gillan and Cutz, 1993; Johnson et al., 1982 Johnson et al., ,1985 . The increased numbers of NEBs in advanced BPD may reflect a response to chronic local hyp-oxia and/or increased production of growth factors such as bombesin. Lauweryns first suggested that some pulmonary neuroendocrine cells in NEBs might be functioning as chemoreceptors, responding to airway hypoxia (Lauweryns and Van Lommel, 1986; Lauweryns et al., 1978 Lauweryns et al., ,1983 Lauweryns and Peuskens, 1972) . Recently, Cutz has identified the presence of an oxygen-sensitive potassium channel coupled to an oxygen-sensitive protein in cultured cells of pulmonary NEBS, indicating that they are transducers of the h*xi c response ( Youngson et al., 1993) . The "crowns" of Clara cells ovqr luminal surfaces of NEBS may limit the number of chemosensitive elements exposed to alveolar air and thereby be activated for transduction of the hypoxic response.
In this study, in situ hybridization localization of the CCSP gene was performed only on respiratory tissue. However, immunohistochemical examination of a variety of nonpulmonary tissues demonstrated CCSP immunoreactivity in cells in the transitional epithelium of the prostatic urethra. This is not in concordance with other immunohistochemical studies of human tissues (Singh et al., 1988a) . However, using reverse transcriptase polymerase chain reaction, human CCSP mRNA was detected in the lung and in several nonrespiratory organs, with a distribution pattern very similar, if not identical, to that of uteroglobin in the rabbit (Peri et al., 1993 (Peri et al., , 1994 . These data suggest that the human urogenital tract contains low levels of CCSP gene products, which can only be detected by methods of high sensitivity.
Properties of this family of proteins include inhibition of phospholipase Az (Miele et al., 1990) and reduction of foreign protein antigenicity by forming a complex with transglutaminase (Mantile et al., 1993) . The inhibition of phospholipase A2 by CCSP may serve to inhibit arachidonate release and modulate the inflammatory response. Because PLAzs catalyze formation of lysophosphatidylcholine, a major factor in surfactant inactivation, CCSP may play a role in protecting surfactant phospholipids from PLA2 catalyzed degradation (Guy et al., 1992) .
In summary, we have described the temporal-spatial distribution of Clara cells during human fetal life and during the repair of neonatal lung disease. We have demonstrated their close association with NEBs but find no evidence of their common lineage. In contrast, a common lineage is suggested for cells expressing CCSP, SP-A and pro-SP-B in early development, with later divergence.
